Literature DB >> 12569164

Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis.

Despina Moshous1, Christophe Pannetier, Régina de Chasseval Rd, Françoise le Deist Fl, Marina Cavazzana-Calvo, Serge Romana, Elizabeth Macintyre, Danielle Canioni, Nicole Brousse, Alain Fischer, Jean-Laurent Casanova, Jean-Pierre de Villartay.   

Abstract

We have previously described the identification of Artemis, a factor involved in the nonhomologous end joining (NHEJ) phase of V(D)J recombination of T and B cell receptor genes. Null mutations of the Artemis gene result in a complete absence of T and B lymphocytes that is associated with increased cell radiosensitivity, causing the radiosensitive T(-)B(-) SCID (RS-SCID) condition. We presently report the occurrence of hypomorphic mutations of the Artemis gene in four patients from two kindreds. Partially preserved in vivo activity of Artemis is associated with the presence of polyclonal T and B lymphocyte populations, albeit in reduced numbers, along with chromosomal instability and development of EBV-associated lymphoma in two of four patients. This syndrome emphasizes the role of Artemis in the NHEJ pathway of DNA repair and suggests that other, yet ill-defined, conditions associating immunodeficiency and lymphoma could be caused by mutations in genes encoding NHEJ factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12569164      PMCID: PMC151863          DOI: 10.1172/JCI16774

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Regulated genomic instability and neoplasia in the lymphoid lineage.

Authors:  G J Vanasse; P Concannon; D M Willerford
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Identification of basic residues in RAG2 critical for DNA binding by the RAG1-RAG2 complex.

Authors:  S D Fugmann; D G Schatz
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

3.  An evolutionary classification of the metallo-beta-lactamase fold proteins.

Authors:  L Aravind
Journal:  In Silico Biol       Date:  1999

Review 4.  DNA double strand break repair and chromosomal translocation: lessons from animal models.

Authors:  D O Ferguson; F W Alt
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

5.  Modulation of terminal deoxynucleotidyltransferase activity by the DNA-dependent protein kinase.

Authors:  S Mickelsen; C Snyder; K Trujillo; M Bogue; D B Roth; K Meek
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

6.  Association of terminal deoxynucleotidyl transferase with Ku.

Authors:  K N Mahajan; L Gangi-Peterson; D H Sorscher; J Wang; K N Gathy; N P Mahajan; W H Reeves; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

7.  Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.

Authors:  B Corneo; D Moshous; T Güngör; N Wulffraat; P Philippet; F L Le Deist; A Fischer; J P de Villartay
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

8.  Ku80 is required for addition of N nucleotides to V(D)J recombination junctions by terminal deoxynucleotidyl transferase.

Authors:  M M Purugganan; S Shah; J F Kearney; D B Roth
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

9.  Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.

Authors:  D Moshous; I Callebaut; R de Chasseval; B Corneo; M Cavazzana-Calvo; F Le Deist; I Tezcan; O Sanal; Y Bertrand; N Philippe; A Fischer; J P de Villartay
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

10.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.

Authors:  A Villa; C Sobacchi; L D Notarangelo; F Bozzi; M Abinun; T G Abrahamsen; P D Arkwright; M Baniyash; E G Brooks; M E Conley; P Cortes; M Duse; A Fasth; A M Filipovich; A J Infante; A Jones; E Mazzolari; S M Muller; S Pasic; G Rechavi; M G Sacco; S Santagata; M L Schroeder; R Seger; D Strina; A Ugazio; J Väliaho; M Vihinen; L B Vogler; H Ochs; P Vezzoni; W Friedrich; K Schwarz
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

View more
  54 in total

Review 1.  Unravelling the web of DNA repair disorders.

Authors:  A R Gennery; M O'Driscoll
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 2.  Artemis: guarding small children and, now, the genome.

Authors:  Vicky L Brandt; David B Roth
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

3.  Autoinhibition of the Nuclease ARTEMIS Is Mediated by a Physical Interaction between Its Catalytic and C-terminal Domains.

Authors:  Doris Niewolik; Ingrid Peter; Carmen Butscher; Klaus Schwarz
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

Review 4.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

5.  Differential usage of alternative pathways of double-strand break repair in Drosophila.

Authors:  Christine R Preston; Carlos C Flores; William R Engels
Journal:  Genetics       Date:  2005-11-19       Impact factor: 4.562

Review 6.  Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection.

Authors:  Michel H Bourguignon; Pablo A Gisone; Maria R Perez; Severino Michelin; Diana Dubner; Marina Di Giorgio; Edgardo D Carosella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

7.  The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair.

Authors:  Suk-Hee Lee; Masahiko Oshige; Stephen T Durant; Kanwaldeep Kaur Rasila; Elizabeth A Williamson; Heather Ramsey; Lori Kwan; Jac A Nickoloff; Robert Hromas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

Review 8.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

9.  Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.

Authors:  Kerstin Felgentreff; Yu Nee Lee; Francesco Frugoni; Likun Du; Mirjam van der Burg; Silvia Giliani; Ilhan Tezcan; Ismail Reisli; Ester Mejstrikova; Jean-Pierre de Villartay; Barry P Sleckman; John Manis; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2015-04-25       Impact factor: 10.793

10.  Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency.

Authors:  Jan Rohr; Ulrich Pannicke; Michaela Döring; Annette Schmitt-Graeff; Elisabeth Wiech; Andreas Busch; Carsten Speckmann; Ingo Müller; Peter Lang; Rupert Handgretinger; Paul Fisch; Klaus Schwarz; Stephan Ehl
Journal:  J Clin Immunol       Date:  2009-12-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.